{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T17:10:27Z","timestamp":1792602627533,"version":"4.5.0"},"reference-count":282,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Controlled Release"],"published-print":{"date-parts":[[2020,11]]},"DOI":"10.1016\/j.jconrel.2020.07.044","type":"journal-article","created":{"date-parts":[[2020,7,31]],"date-time":"2020-07-31T07:13:28Z","timestamp":1596179608000},"page":"235-265","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":286,"special_numbering":"C","title":["Stimuli-responsive In situ gelling system for nose-to-brain drug delivery"],"prefix":"10.1016","volume":"327","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1857-7698","authenticated-orcid":false,"given":"Mukta","family":"Agrawal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shailendra","family":"Saraf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Swarnlata","family":"Saraf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sunil K.","family":"Dubey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4792-6583","authenticated-orcid":false,"given":"Anu","family":"Puri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8947-2749","authenticated-orcid":false,"given":"Umesh","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prashant","family":"Kesharwani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V.","family":"Ravichandiran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0346-7242","authenticated-orcid":false,"given":"Pramod","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V.G.M.","family":"Naidu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Upadhyayula Suryanarayana","family":"Murty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"family":"Ajazuddin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0391-7650","authenticated-orcid":false,"given":"Amit","family":"Alexander","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jconrel.2020.07.044_bb0005","series-title":"Mental Health","article-title":"Neurological disorders: public health challenges","author":"WHO","year":"2019"},{"key":"10.1016\/j.jconrel.2020.07.044_bb0010","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1016\/S1474-4422(19)30029-8","article-title":"The global burden of neurological disorders","volume":"18","author":"Carroll","year":"2019","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.jconrel.2020.07.044_bb0015","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.ijpharm.2016.10.024","article-title":"Promises of a biocompatible nanocarrier in improved brain delivery of quercetin: Biochemical, pharmacokinetic and biodistribution evidences","volume":"515","author":"Kumar","year":"2016","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2020.07.044_bb0020","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.jconrel.2018.05.011","article-title":"Nose-to-brain drug delivery: An update on clinical challenges and progress towards approval of anti-Alzheimer drugs","volume":"281","author":"Agrawal","year":"2018","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2020.07.044_bb0025","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/S1474-4422(18)30499-X","article-title":"Global, regional, and national burden of neurological disorders, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016","volume":"18","year":"2019","journal-title":"The Lancet. Neurol."},{"key":"10.1016\/j.jconrel.2020.07.044_bb0030","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1080\/17425247.2018.1471058","article-title":"Recent advancements in the field of nanotechnology for the delivery of anti-Alzheimer drug in the brain region","volume":"15","author":"Agrawal","year":"2018","journal-title":"Expert Opin. Drug Deliv."},{"key":"10.1016\/j.jconrel.2020.07.044_bb0035","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1111\/dmcn.12079","article-title":"Prevalence and risk factors for neurological disorders in children aged 6 months to 2 years in northern India","volume":"55","author":"Kumar","year":"2013","journal-title":"Dev. Med. Child Neurol."},{"key":"10.1016\/j.jconrel.2020.07.044_bb0040","doi-asserted-by":"crossref","first-page":"S151","DOI":"10.1038\/nature16028","article-title":"Brain and other nervous system disorders across the lifespan - global challenges and opportunities","volume":"527","author":"Silberberg","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.jconrel.2020.07.044_bb0045","doi-asserted-by":"crossref","first-page":"3259","DOI":"10.2147\/IJN.S30919","article-title":"Neurological disorders and therapeutics targeted to surmount the blood-brain barrier","volume":"7","author":"Kanwar","year":"2012","journal-title":"Int. J. Nanomedicine"},{"key":"10.1016\/j.jconrel.2020.07.044_bb0050","doi-asserted-by":"crossref","first-page":"117540","DOI":"10.1016\/j.lfs.2020.117540","article-title":"Insulin mediated novel therapies for the treatment of Alzheimer's disease","volume":"249","author":"Dubey","year":"2020","journal-title":"Life Sci."},{"key":"10.1016\/j.jconrel.2020.07.044_bb0055","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics10020040","article-title":"In situ-based gels for nose to brain delivery for the treatment of neurological diseases","volume":"10","author":"Aderibigbe","year":"2018","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.jconrel.2020.07.044_bb0060","doi-asserted-by":"crossref","first-page":"5895","DOI":"10.2147\/IJN.S210876","article-title":"Recent expansions of novel strategies towards the drug targeting into the brain","volume":"14","author":"Alexander","year":"2019","journal-title":"Int. J. Nanomedicine"},{"key":"10.1016\/j.jconrel.2020.07.044_bb0065","doi-asserted-by":"crossref","first-page":"869269","DOI":"10.1155\/2014\/869269","article-title":"Drug delivery systems, CNS protection, and the blood brain barrier","volume":"2014","author":"Upadhyay","year":"2014","journal-title":"Biomed. Res. Int."},{"key":"10.1016\/j.jconrel.2020.07.044_bb0070","first-page":"266","article-title":"Treatment of neurological and psychiatric disorders with deep brain stimulation; raising hopes and future challenges","volume":"4","author":"Sharifi","year":"2013","journal-title":"Basic Clin. Neurosci."},{"key":"10.1016\/j.jconrel.2020.07.044_bb0075","series-title":"BSAVA Manual of Canine and Feline Neurology","article-title":"Lesion localization and differential diagnosis","author":"Garosi","year":"2013"},{"key":"10.1016\/j.jconrel.2020.07.044_bb0080","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1007\/s10571-019-00653-z","article-title":"Recent expansions on cellular models to uncover the scientific barriers towards drug development for alzheimer's disease","volume":"39","author":"Dubey","year":"2019","journal-title":"Cell. Mol. Neurobiol."},{"key":"10.1016\/j.jconrel.2020.07.044_bb0085","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/j.it.2008.05.002","article-title":"Why neurodegenerative diseases are progressive: uncontrolled inflammation drives disease progression","volume":"29","author":"Gao","year":"2008","journal-title":"Trends Immunol."},{"key":"10.1016\/j.jconrel.2020.07.044_bb0090","series-title":"Epilepsy in the Elderly: Some Clinical and Pharmacotherapeutic Aspects","first-page":"55","volume":"42","author":"Kr\u00e4mer","year":"2001"},{"key":"10.1016\/j.jconrel.2020.07.044_bb0095","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1038\/nrn1700","article-title":"Role of the immune system in chronic pain","volume":"6","author":"Marchand","year":"2005","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.jconrel.2020.07.044_bb0100","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1007\/s12012-019-09543-8","article-title":"proarrhythmic effect of acetylcholine-esterase inhibitors used in the treatment of alzheimer's disease: benefit of rivastigmine in an experimental whole-heart model","volume":"20","author":"Ellermann","year":"2020","journal-title":"Cardiovasc. Toxicol."},{"key":"10.1016\/j.jconrel.2020.07.044_bb0105","doi-asserted-by":"crossref","first-page":"11","DOI":"10.2165\/00002018-199819010-00002","article-title":"Safety of selegiline (deprenyl) in the treatment of Parkinson's disease","volume":"19","author":"Heinonen","year":"1998","journal-title":"Drug Saf."},{"issue":"27","key":"10.1016\/j.jconrel.2020.07.044_bb0110","doi-asserted-by":"crossref","first-page":"3269","DOI":"10.2174\/1381612826666200212120947","article-title":"Formulation strategies of nano lipid carrier for effective brain targeting of anti-AD drugs","volume":"26","author":"Alexander","year":"2020","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.jconrel.2020.07.044_bb0115","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/S1474-4422(14)70251-0","article-title":"Pharmacotherapy for neuropathic pain in adults: a systematic review and meta-analysis","volume":"14","author":"Finnerup","year":"2015","journal-title":"The Lancet. Neurol."},{"key":"10.1016\/j.jconrel.2020.07.044_bb0120","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1001\/archneur.1976.00500110007002","article-title":"Single-agent chemotherapy of brain tumors. A five-year review","volume":"33","author":"Wilson","year":"1976","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.jconrel.2020.07.044_bb0125","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1007\/s11095-011-0572-9","article-title":"Delivery of brain-derived neurotrophic factor via nose-to-brain pathway","volume":"29","author":"Vaka","year":"2012","journal-title":"Pharm. Res."},{"key":"10.1016\/j.jconrel.2020.07.044_bb0130","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1021\/acschemneuro.6b00428","article-title":"Enhanced brain delivery of dimethyl fumarate employing tocopherol-acetate-based nanolipidic carriers: evidence from pharmacokinetic, biodistribution, and cellular uptake studies","volume":"8","author":"Kumar","year":"2017","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.jconrel.2020.07.044_bb0135","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.ijpharm.2019.05.032","article-title":"Targeted drug delivery to the brain via intranasal nanoemulsion: available proof of concept and existing challenges","volume":"565","author":"Chatterjee","year":"2019","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2020.07.044_bb0140","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.jconrel.2017.05.019","article-title":"Alexander, recent advancements in liposomes targeting strategies to cross blood-brain barrier (BBB) for the treatment of Alzheimer's disease","volume":"260","author":"Agrawal","year":"2017","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2020.07.044_bb0145","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/j.jconrel.2020.02.020","article-title":"Recent strategies and advances in the fabrication of nano lipid carriers and their application towards brain targeting","volume":"321","author":"Agrawal","year":"2020","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2020.07.044_bb0150","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1517\/17425247.2013.746659","article-title":"Mucoadhesive in situ nasal gelling drug delivery systems for modulated drug delivery","volume":"10","author":"Singh","year":"2013","journal-title":"Expert Opin. Drug Deliv."},{"key":"10.1016\/j.jconrel.2020.07.044_bb0155","doi-asserted-by":"crossref","first-page":"119491","DOI":"10.1016\/j.biomaterials.2019.119491","article-title":"Nanomaterial-based blood-brain-barrier (BBB) crossing strategies","volume":"224","author":"Xie","year":"2019","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2020.07.044_bb0160","doi-asserted-by":"crossref","first-page":"119657","DOI":"10.1016\/j.biomaterials.2019.119657","article-title":"Nose-to-brain delivery of enveloped RNA - cell permeating peptide nanocomplexes for the treatment of neurodegenerative diseases","volume":"230","author":"Samaridou","year":"2020","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2020.07.044_bb0165","doi-asserted-by":"crossref","first-page":"288","DOI":"10.18433\/J3NC79","article-title":"Intranasal drug delivery: how, why and what for?","volume":"12","author":"Pires","year":"2009","journal-title":"J. Pharm. Pharm. Sci."},{"key":"10.1016\/j.jconrel.2020.07.044_bb0170","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1016\/S1359-6446(02)02452-2","article-title":"Permeability issues in nasal drug delivery","volume":"7","author":"Arora","year":"2002","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.jconrel.2020.07.044_bb0175","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1615\/CritRevTherDrugCarrierSyst.2013007362","article-title":"In situ gel-forming system: an attractive alternative for nasal drug delivery","volume":"30","author":"Wang","year":"2013","journal-title":"Crit. Rev. Ther. Drug Carrier Syst."},{"key":"10.1016\/j.jconrel.2020.07.044_bb0180","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.drudis.2015.10.016","article-title":"Smart materials: in situ gel-forming systems for nasal delivery","volume":"21","author":"Karavasili","year":"2016","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.jconrel.2020.07.044_bb0185","doi-asserted-by":"crossref","first-page":"187","DOI":"10.2174\/1574888X15666200103124821","article-title":"Uncovering the diversification of tissue engineering on the emergent areas of stem cells","volume":"15","author":"Dubey","year":"2020","journal-title":"Nanotechnol. Biomater. Curr. Stem Cell Res. Therapy"},{"key":"10.1016\/j.jconrel.2020.07.044_bb0190","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1080\/01926230600713475","article-title":"The nose revisited: a brief review of the comparative structure, function, and toxicologic pathology of the nasal epithelium","volume":"34","author":"Harkema","year":"2006","journal-title":"Toxicol. Pathol."},{"key":"10.1016\/j.jconrel.2020.07.044_bb0195","doi-asserted-by":"crossref","first-page":"2102","DOI":"10.4103\/1673-5374.241458","article-title":"Nose-to-brain drug delivery approach: a key to easily accessing the brain for the treatment of Alzheimer's disease","volume":"13","author":"Alexander","year":"2018","journal-title":"Neural Regen. Res."},{"key":"10.1016\/j.jconrel.2020.07.044_bb0200","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.lfs.2017.12.025","article-title":"Mechanism of intranasal drug delivery directly to the brain","volume":"195","author":"Crowe","year":"2018","journal-title":"Life Sci."},{"key":"10.1016\/j.jconrel.2020.07.044_bb0205","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/S0169-409X(97)00059-8","article-title":"Nasal mucociliary clearance as a factor in nasal drug delivery","volume":"29","author":"Merkus","year":"1998","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2020.07.044_bb0210","doi-asserted-by":"crossref","first-page":"1654","DOI":"10.1002\/jps.21924","article-title":"Intranasal delivery to the central nervous system: mechanisms and experimental considerations","volume":"99","author":"Dhuria","year":"2010","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.jconrel.2020.07.044_bb0215","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1080\/21691401.2017.1337024","article-title":"Intranasal delivery of quercetin-loaded mucoadhesive nanoemulsion for treatment of cerebral ischaemia","volume":"46","author":"Ahmad","year":"2018","journal-title":"Artif. Cells Nanomed. Biotechnol."},{"key":"10.1016\/j.jconrel.2020.07.044_bb0220","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1039\/C6NR07581A","article-title":"Evidence of nose-to-brain delivery of nanoemulsions: cargoes but not vehicles","volume":"9","author":"Ahmad","year":"2017","journal-title":"Nanoscale"},{"key":"10.1016\/j.jconrel.2020.07.044_bb0225","doi-asserted-by":"crossref","first-page":"75","DOI":"10.3109\/10717544.2013.838713","article-title":"Insights into direct nose to brain delivery: current status and future perspective","volume":"21","author":"Mittal","year":"2014","journal-title":"Drug Deliv."},{"key":"10.1016\/j.jconrel.2020.07.044_bb0230","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1016\/j.drudis.2018.01.005","article-title":"An update on the role of nanovehicles in nose-to-brain drug delivery","volume":"23","author":"Feng","year":"2018","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.jconrel.2020.07.044_bb0235","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1517\/17425247.2013.790887","article-title":"Direct nose to brain drug delivery via integrated nerve pathways bypassing the blood-brain barrier: an excellent platform for brain targeting","volume":"10","author":"Pardeshi","year":"2013","journal-title":"Expert Opin. Drug Deliv."},{"key":"10.1016\/j.jconrel.2020.07.044_bb0240","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1128\/CMR.00007-10","article-title":"Penetration of drugs through the blood-cerebrospinal fluid\/blood-brain barrier for treatment of central nervous system infections","volume":"23","author":"Nau","year":"2010","journal-title":"Clin. Microbiol. Rev."},{"key":"10.1016\/j.jconrel.2020.07.044_bb0245","series-title":"World Alzheimer Report 2016: Improving Healthcare for People Living with Dementia: Coverage, Quality and Costs now and in the Future","author":"Prince","year":"2016"},{"key":"10.1016\/j.jconrel.2020.07.044_bb0250","first-page":"40","article-title":"Intranasal drug delivery bypasses the blood\u2013brain barrier","volume":"24","author":"Frey","year":"2016","journal-title":"Neurol. Rev."},{"key":"10.1016\/j.jconrel.2020.07.044_bb0255","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1016\/j.addr.2011.11.002","article-title":"Intranasal delivery of biologics to the central nervous system","volume":"64","author":"Lochhead","year":"2012","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2020.07.044_bb0260","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1007\/BF00688493","article-title":"Uptake of exogenous proteins in mouse olfactory cells","volume":"19","author":"Kristensson","year":"1971","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.jconrel.2020.07.044_bb0265","doi-asserted-by":"crossref","first-page":"279","DOI":"10.3109\/1061186X.2013.876644","article-title":"Intranasal therapeutic strategies for management of Alzheimer's disease","volume":"22","author":"Sood","year":"2014","journal-title":"J. Drug Target."},{"key":"10.1016\/j.jconrel.2020.07.044_bb0270","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.brainresbull.2018.10.009","article-title":"Evaluation of intranasal delivery route of drug administration for brain targeting","volume":"143","author":"Erd\u0151","year":"2018","journal-title":"Brain Res. Bull."},{"issue":"Suppl. 3","key":"10.1016\/j.jconrel.2020.07.044_bb0275","article-title":"Intranasal delivery bypasses the blood-brain barrier to target therapeutic agents to the central nervous system and treat neurodegenerative disease","volume":"9","author":"Hanson","year":"2008","journal-title":"BMC Neurosci."},{"key":"10.1016\/j.jconrel.2020.07.044_bb0280","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0928-0987(00)00087-7","article-title":"Transport of drugs from the nasal cavity to the central nervous system","volume":"11","author":"Illum","year":"2000","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.jconrel.2020.07.044_bb0285","series-title":"Cilia and Mucociliary Clearance, Cold Spring Harbor perspectives in biology, 9","author":"Bustamante-Marin","year":"2017"},{"key":"10.1016\/j.jconrel.2020.07.044_bb0290","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1211\/0022357011775145","article-title":"The biopharmaceutical aspects of nasal mucoadhesive drug delivery","volume":"53","author":"Ugwoke","year":"2001","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.jconrel.2020.07.044_bb0295","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/S0378-5173(98)00367-6","article-title":"Evaluation of the clearance characteristics of bioadhesive systems in humans","volume":"178","author":"Soane","year":"1999","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2020.07.044_bb0300","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1016\/S1359-6446(02)02529-1","article-title":"Nasal drug delivery: new developments and strategies","volume":"7","author":"Illum","year":"2002","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.jconrel.2020.07.044_bb0305","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.4155\/tde.13.104","article-title":"Basics and recent advances in peptide and protein drug delivery","volume":"4","author":"Bruno","year":"2013","journal-title":"Ther. Deliv."},{"key":"10.1016\/j.jconrel.2020.07.044_bb0310","doi-asserted-by":"crossref","first-page":"969","DOI":"10.3109\/10717544.2013.879355","article-title":"Comprehensive review on additives of topical dosage forms for drug delivery","volume":"22","author":"Garg","year":"2015","journal-title":"Drug Deliv."},{"key":"10.1016\/j.jconrel.2020.07.044_bb0315","first-page":"1167","article-title":"In situ nasal gel drug delivery: a novel approach for brain targeting through the mucosal membrane","volume":"44","author":"Kaur","year":"2016","journal-title":"Artif. Cells Nanomed. Biotechnol."},{"key":"10.1016\/j.jconrel.2020.07.044_bb0320","doi-asserted-by":"crossref","first-page":"118","DOI":"10.5897\/AJPP2019.5008","article-title":"Nanotechnology: a non-invasive diagnosis and therapeutic tool for brain disorders","volume":"13","author":"Amit Alexander","year":"2019","journal-title":"Afr. J. Pharm. Pharmacol"},{"key":"10.1016\/j.jconrel.2020.07.044_bb0325","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.jfda.2014.01.012","article-title":"Neurotoxicity of nanoscale materials","volume":"22","author":"Karmakar","year":"2014","journal-title":"J. Food Drug Anal."},{"key":"10.1016\/j.jconrel.2020.07.044_bb0330","doi-asserted-by":"crossref","first-page":"549","DOI":"10.3389\/fbioe.2020.00549","article-title":"In vitro alternatives to acute inhalation toxicity studies in animal models-A perspective","volume":"8","author":"Movia","year":"2020","journal-title":"Front. Bioeng. Biotechnol."},{"key":"10.1016\/j.jconrel.2020.07.044_bb0335","series-title":"Nanoemulsions for \"Nose-to-Brain\" Drug Delivery, Pharmaceutics, 11","author":"Bonferoni","year":"2019"},{"key":"10.1016\/j.jconrel.2020.07.044_bb0340","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1080\/107175499266823","article-title":"Toxicological Implications of Nasal Formulations","volume":"6","author":"Quadir","year":"1999","journal-title":"Drug Deliv."},{"key":"10.1016\/j.jconrel.2020.07.044_bb0345","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1001\/archotol.134.6.643","article-title":"Intranasal Administration of Drugs","volume":"134","author":"Scheibe","year":"2008","journal-title":"Arch. Otolaryngol. Head Neck Surg."},{"key":"10.1016\/j.jconrel.2020.07.044_bb0350","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.drudis.2015.10.016","article-title":"Smart materials: in situ gel-forming systems for nasal delivery","volume":"21","author":"Karavasili","year":"2016","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.jconrel.2020.07.044_bb0355","series-title":"Polymeric Hydrogels as Technology Platform for Drug Delivery Applications, Gels (Basel, Switzerland), 3","author":"Sosnik","year":"2017"},{"key":"10.1016\/j.jconrel.2020.07.044_bb0360","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1039\/C5SM02710A","article-title":"Recent trends in pH\/thermo-responsive self-assembling hydrogels: from polyions to peptide-based polymeric gelators","volume":"12","author":"Chassenieux","year":"2016","journal-title":"Soft Matter"},{"key":"10.1016\/j.jconrel.2020.07.044_bb0365","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1016\/j.drudis.2016.12.008","article-title":"In vitro and in vivo evaluation of in situ gelling systems for sustained topical ophthalmic delivery: state of the art and beyond","volume":"22","author":"Destruel","year":"2017","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.jconrel.2020.07.044_bb0370","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/j.drudis.2013.10.001","article-title":"In situ gelling systems: a strategy to improve the bioavailability of ophthalmic pharmaceutical formulations","volume":"19","author":"Almeida","year":"2014","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.jconrel.2020.07.044_bb0375","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.ijbiomac.2012.11.026","article-title":"A novel injectable temperature-sensitive zinc doped chitosan\/beta-glycerophosphate hydrogel for bone tissue engineering","volume":"54","author":"Niranjan","year":"2013","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.jconrel.2020.07.044_bb0380","series-title":"Development and characterisation of thermo reversible mucoadhesive moxifloxacin hydrochloride in situ ophthalmic gel","author":"Dholakia","year":"2012"},{"key":"10.1016\/j.jconrel.2020.07.044_bb0385","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/S0169-409X(97)00063-X","article-title":"Effects of physicochemical properties and other factors on systemic nasal drug delivery","volume":"29","author":"Romeo","year":"1998","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2020.07.044_bb0390","doi-asserted-by":"crossref","first-page":"367","DOI":"10.4103\/0250-474X.164770","article-title":"Smart polymers in nasal drug delivery","volume":"77","author":"Chonkar","year":"2015","journal-title":"Indian J. Pharm. Sci."},{"key":"10.1016\/j.jconrel.2020.07.044_bb0395","series-title":"Review of Stimuli-Responsive Polymers in Drug Delivery and Textile Application, Molecules (Basel, Switzerland), 24","author":"Chatterjee","year":"2019"},{"key":"10.1016\/j.jconrel.2020.07.044_bb0400","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/0378-5173(85)90197-8","article-title":"The micellar properties of the poly(oxyethylene) - poly(oxypropylene) copolymer Pluronic F127 in water and electrolyte solution","volume":"26","author":"Attwood","year":"1985","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2020.07.044_bb0405","first-page":"466","article-title":"Development and evaluation of in situ nasal gel formulations of loratadine","volume":"10","author":"Sherafudeen","year":"2015","journal-title":"Res. Pharm. Sci."},{"key":"10.1016\/j.jconrel.2020.07.044_bb0410","series-title":"Mucosal Applications of Poloxamer 407-Based Hydrogels: An Overview, 10","author":"Giuliano","year":"2018"},{"key":"10.1016\/j.jconrel.2020.07.044_bb0415","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/S1359-6446(01)01824-4","article-title":"Temperature-sensitive gels: from tissue engineering to drug delivery","volume":"6","author":"Habeck","year":"2001","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.jconrel.2020.07.044_bb0420","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1080\/08982104.2018.1552703","article-title":"Nanostructured cubosomes in an in situ nasal gel system: an alternative approach for the controlled delivery of donepezil HCl to brain","volume":"29","author":"Patil","year":"2019","journal-title":"J. Liposome Res."},{"key":"10.1016\/j.jconrel.2020.07.044_bb0425","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1016\/j.drudis.2019.05.036","article-title":"Poloxamer-based in situ gelling thermoresponsive systems for ocular drug delivery applications","volume":"24","author":"Soliman","year":"2019","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.jconrel.2020.07.044_bb0430","series-title":"Injectable Biomaterials","first-page":"61","article-title":"4 - Improving mechanical properties of injectable polymers and composites","author":"Qiu","year":"2011"},{"key":"10.1016\/j.jconrel.2020.07.044_bb0435","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0927-7757(94)03028-X","article-title":"Poly(ethylene oxide) poly(propylene oxide) poly(ethylene oxide) block copolymer surfactants in aqueous solutions and at interfaces: thermodynamics, structure, dynamics, and modeling","volume":"96","author":"Alexandridis","year":"1995","journal-title":"Colloids Surf. A Physicochem. Eng. Asp."},{"key":"10.1016\/j.jconrel.2020.07.044_bb0440","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/j.pharmthera.2012.03.003","article-title":"Intranasal drug delivery: an efficient and non-invasive route for systemic administration: focus on opioids","volume":"134","author":"Grassin-Delyle","year":"2012","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.jconrel.2020.07.044_bb0445","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.ijpharm.2003.10.005","article-title":"Pluronic gels for nasal delivery of Vitamin B12. Part I: preformulation study","volume":"270","author":"Pisal","year":"2004","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2020.07.044_bb0450","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1163\/156856203763572680","article-title":"Crosslinkable PEO-PPO-PEO-based reverse thermo-responsive gels as potentially injectable materials","volume":"14","author":"Sosnik","year":"2003","journal-title":"J. Biomater. Sci."},{"key":"10.1016\/j.jconrel.2020.07.044_bb0455","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1163\/1568562042459751","article-title":"Photo-crosslinkable, thermo-sensitive and biodegradable pluronic hydrogels for sustained release of protein","volume":"15","author":"Lee","year":"2004","journal-title":"J. Biomater. Sci."},{"key":"10.1016\/j.jconrel.2020.07.044_bb0460","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.colsurfb.2010.10.041","article-title":"Micelles from PEO-PPO-PEO block copolymers as nanocontainers for solubilization of a poorly water soluble drug hydrochlorothiazide, colloids and surfaces B","volume":"83","author":"Kadam","year":"2011","journal-title":"Biointerfaces"},{"key":"10.1016\/j.jconrel.2020.07.044_bb0465","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.colsurfb.2011.12.034","article-title":"Preparation and optimization of media using Pluronic(R) micelles for solubilization of sirolimus and release from the drug eluting stents, Colloids and surfaces B","volume":"93","author":"Raval","year":"2012","journal-title":"Biointerfaces"},{"key":"10.1016\/j.jconrel.2020.07.044_bb0470","doi-asserted-by":"crossref","first-page":"138","DOI":"10.5414\/CPP48138","article-title":"Pharmacokinetic comparisons of three nasal fentanyl formulations; pectin, chitosan and chitosan-poloxamer 188","volume":"48","author":"Fisher","year":"2010","journal-title":"Int. J. Clin. Pharmacol. Ther."},{"key":"10.1016\/j.jconrel.2020.07.044_bb0475","doi-asserted-by":"crossref","first-page":"282","DOI":"10.2174\/156720108785914952","article-title":"Phase transition system: novel oral in-situ gel","volume":"5","author":"Nagarwal","year":"2008","journal-title":"Curr. Drug Deliv."},{"key":"10.1016\/j.jconrel.2020.07.044_bb0480","doi-asserted-by":"crossref","first-page":"6151","DOI":"10.1016\/j.biomaterials.2009.07.060","article-title":"In situ gelling properties of chitosan-thioglycolic acid conjugate in the presence of oxidizing agents","volume":"30","author":"Sakloetsakun","year":"2009","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2020.07.044_bb0485","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/j.biomaterials.2006.08.044","article-title":"Polylysine-functionalised thermoresponsive chitosan hydrogel for neural tissue engineering","volume":"28","author":"Crompton","year":"2007","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2020.07.044_bb0490","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1002\/bip.360300322","article-title":"On the physicochemical properties of gellan gum","volume":"30","author":"Milas","year":"1990","journal-title":"Biopolymers"},{"key":"10.1016\/j.jconrel.2020.07.044_bb0495","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1002\/mabi.201100422","article-title":"Injectable in situ physically and chemically crosslinkable gellan hydrogel","volume":"12","author":"Du","year":"2012","journal-title":"Macromol. Biosci."},{"key":"10.1016\/j.jconrel.2020.07.044_bb0500","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1248\/cpb.50.1335","article-title":"Irradiating or autoclaving chitosan\/polyol solutions: effect on thermogelling chitosan-beta-glycerophosphate systems","volume":"50","author":"Jarry","year":"2002","journal-title":"Chem. Pharm. Bull."},{"key":"10.1016\/j.jconrel.2020.07.044_bb0505","doi-asserted-by":"crossref","first-page":"4157","DOI":"10.1016\/j.biomaterials.2010.01.139","article-title":"A chitosan\/beta-glycerophosphate thermo-sensitive gel for the delivery of ellagic acid for the treatment of brain cancer","volume":"31","author":"Kim","year":"2010","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2020.07.044_bb0510","doi-asserted-by":"crossref","first-page":"3267","DOI":"10.1021\/bm050313s","article-title":"Physical gelation of chitosan in the presence of beta-glycerophosphate: the effect of temperature","volume":"6","author":"Cho","year":"2005","journal-title":"Biomacromolecules"},{"key":"10.1016\/j.jconrel.2020.07.044_bb0515","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/S0169-409X(98)00073-8","article-title":"Intranasal insulin delivery and therapy","volume":"35","author":"Hinchcliffe","year":"1999","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2020.07.044_bb0520","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1016\/j.ijpharm.2012.07.018","article-title":"Thermoresponsive hydrogels with low toxicity from mixtures of ethyl(hydroxyethyl) cellulose and arginine-based surfactants","volume":"436","author":"Calejo","year":"2012","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2020.07.044_bb0525","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1021\/la00003a014","article-title":"Rheological behavior during thermoreversible gelation of aqueous mixtures of Ethyl(hydroxyethyl)cellulose and surfactants","volume":"11","author":"Nystroem","year":"1995","journal-title":"Langmuir"},{"key":"10.1016\/j.jconrel.2020.07.044_bb0530","doi-asserted-by":"crossref","first-page":"1852","DOI":"10.1021\/ma9714427","article-title":"Dynamic viscoelasticity of gelling and nongelling aqueous mixtures of ethyl(hydroxyethyl)cellulose and an ionic surfactant","volume":"31","author":"Kj\u00f8niksen","year":"1998","journal-title":"Macromolecules"},{"key":"10.1016\/j.jconrel.2020.07.044_bb0535","doi-asserted-by":"crossref","first-page":"1826","DOI":"10.1016\/j.carres.2005.04.016","article-title":"Structural analysis of xyloglucans in the primary cell walls of plants in the subclass Asteridae","volume":"340","author":"Hoffman","year":"2005","journal-title":"Carbohydr. Res."},{"key":"10.1016\/j.jconrel.2020.07.044_bb0540","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.bpc.2005.12.005","article-title":"Morphology and gelation of thermosensitive xyloglucan hydrogels","volume":"121","author":"Nisbet","year":"2006","journal-title":"Biophys. Chem."},{"key":"10.1016\/j.jconrel.2020.07.044_bb0545","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1208\/s12249-017-0844-8","article-title":"Development and evaluation of pH-responsive cyclodextrin-based in situ gel of paliperidone for intranasal delivery","volume":"19","author":"Sherje","year":"2018","journal-title":"AAPS PharmSciTech"},{"key":"10.1016\/j.jconrel.2020.07.044_bb0550","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/S0168-3659(00)00329-1","article-title":"Carbopol\/pluronic phase change solutions for ophthalmic drug delivery","volume":"69","author":"Lin","year":"2000","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2020.07.044_bb0555","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/S0378-5173(99)00338-5","article-title":"Mucoadhesive suppositories of ramosetron hydrochloride utilizing carbopol","volume":"193","author":"Yahagi","year":"2000","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2020.07.044_bb0560","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/0144-8617(87)90004-X","article-title":"Gelation of gellan gum","volume":"7","author":"Grasdalen","year":"1987","journal-title":"Carbohydr. Polym."},{"key":"10.1016\/j.jconrel.2020.07.044_bb0565","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1002\/jps.10371","article-title":"Improvement in the in situ gelling properties of deacetylated gellan gum by the immobilization of thiol groups","volume":"92","author":"Krauland","year":"2003","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.jconrel.2020.07.044_bb0570","series-title":"Gelation mechanism and network structure of mixed solution of low- and high-acyl gellan studied by dynamic viscoelasticity","author":"Matsukawa","year":"2007"},{"key":"10.1016\/j.jconrel.2020.07.044_bb0575","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/S0268-005X(02)00075-9","article-title":"Rheological properties of gellan solutions: effect of calcium ions and temperature on pre-gel formation","volume":"17","author":"Nickerson","year":"2003","journal-title":"Food Hydrocoll."},{"key":"10.1016\/j.jconrel.2020.07.044_bb0580","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.bej.2011.02.017","article-title":"Influence of gellan gum concentration on the dynamic viscoelasticity and transient flow of fluid gels","volume":"55","author":"Garc\u00eda","year":"2011","journal-title":"Biochem. Eng. J."},{"key":"10.1016\/j.jconrel.2020.07.044_bb0585","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/S0268-005X(09)80239-7","article-title":"Viscoelastic properties of aqueous gellan solutions: the effects of concentration on gelation","volume":"7","author":"Nakamura","year":"1993","journal-title":"Food Hydrocoll."},{"key":"10.1016\/j.jconrel.2020.07.044_bb0590","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1016\/S0963-9969(01)00112-0","article-title":"Effect of polymer ratio and calcium concentration on gelation properties of gellan\/gelatin mixed gels","volume":"34","author":"Lau","year":"2001","journal-title":"Food Res. Int."},{"key":"10.1016\/j.jconrel.2020.07.044_bb0595","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/S0928-0987(99)00051-2","article-title":"Rheological studies of the gelation of deacetylated gellan gum (Gelrite) in physiological conditions","volume":"9","author":"Paulsson","year":"1999","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.jconrel.2020.07.044_bb0600","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.jconrel.2006.12.014","article-title":"Evaluation of bioadhesive polymers as delivery systems for nose to brain delivery: in vitro characterisation studies","volume":"118","author":"Charlton","year":"2007","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2020.07.044_bb0605","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1080\/10717540590929966","article-title":"Pectin gel vehicles for controlled fragrance delivery","volume":"12","author":"Liu","year":"2005","journal-title":"Drug Deliv."},{"key":"10.1016\/j.jconrel.2020.07.044_bb0610","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/j.carres.2009.12.019","article-title":"A new view of pectin structure revealed by acid hydrolysis and atomic force microscopy","volume":"345","author":"Round","year":"2010","journal-title":"Carbohydr. Res."},{"key":"10.1016\/j.jconrel.2020.07.044_bb0615","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.ifset.2009.08.015","article-title":"Influence of pectin structure on texture of pectin\u2013calcium gels","volume":"11","author":"Fraeye","year":"2010","journal-title":"Innovative Food Sci. Emerg. Technol."},{"key":"10.1016\/j.jconrel.2020.07.044_bb0620","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1016\/S0268-005X(03)00101-2","article-title":"Temperature dependence of the formation and melting of pectin\u2013Ca2+ networks: a rheological study","volume":"17","author":"Cardoso","year":"2003","journal-title":"Food Hydrocoll."},{"key":"10.1016\/j.jconrel.2020.07.044_bb0625","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1021\/bm010008g","article-title":"Molecular basis of Ca2+-induced gelation in alginates and pectins: the egg-box model revisited","volume":"2","author":"Braccini","year":"2001","journal-title":"Biomacromolecules"},{"key":"10.1016\/j.jconrel.2020.07.044_bb0630","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.ejpb.2007.01.010","article-title":"Mucoadhesive properties of various pectins on gastrointestinal mucosa: an in vitro evaluation using texture analyzer","volume":"67","author":"Thirawong","year":"2007","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.jconrel.2020.07.044_bb0635","doi-asserted-by":"crossref","first-page":"E15","DOI":"10.1111\/j.1750-3841.2010.01876.x","article-title":"On the formulation design and rheological evaluations of pectin-based functional gels","volume":"76","author":"Haghighi","year":"2011","journal-title":"J. Food Sci."},{"issue":"1","key":"10.1016\/j.jconrel.2020.07.044_bb0640","first-page":"15","article-title":"Heterotopic mucosal engrafting procedure for direct drug delivery to the brain in mice","volume":"76","author":"Kohman","year":"2014","journal-title":"JoVE"},{"key":"10.1016\/j.jconrel.2020.07.044_bb0645","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.wjorl.2015.09.001","article-title":"Bypassing the blood-brian barrier using established skull base reconstruction techniques","volume":"1","author":"Miyake","year":"2015","journal-title":"World J Otorhinolaryngol Head Neck Surg."},{"key":"10.1016\/j.jconrel.2020.07.044_bb0650","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0208122","article-title":"Direct CNS delivery of proteins using thermosensitive liposome-in-gel carrier by heterotopic mucosal engrafting","volume":"13","author":"Pawar","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.jconrel.2020.07.044_bb0655","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1136\/bmj.311.7020.1583","article-title":"Selegiline in Parkinson's disease","volume":"311","author":"Calne","year":"1995","journal-title":"BMJ (Clinical research ed.)"},{"key":"10.1016\/j.jconrel.2020.07.044_bb0660","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1007\/s10072-015-2395-7","article-title":"Prescribing pattern and resource utilization of monoamine oxidase-B inhibitors in Parkinson treatment: comparison between rasagiline and selegiline","volume":"37","author":"Degli Esposti","year":"2016","journal-title":"Neurol. Sci."},{"key":"10.1016\/j.jconrel.2020.07.044_bb0665","first-page":"1480","article-title":"CYP2B6 and CYP2C19 as the major enzymes responsible for the metabolism of selegiline, a drug used in the treatment of Parkinson's disease, as revealed from experiments with recombinant enzymes","volume":"29","author":"Hidestrand","year":"2001","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.jconrel.2020.07.044_bb0670","doi-asserted-by":"crossref","first-page":"1640","DOI":"10.1016\/j.addr.2005.07.009","article-title":"Nasal mucoadhesive drug delivery: background, applications, trends and future perspectives","volume":"57","author":"Ugwoke","year":"2005","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2020.07.044_bb0675","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1080\/1061186X.2017.1350858","article-title":"Brain targeted delivery of mucoadhesive thermosensitive nasal gel of selegiline hydrochloride for treatment of Parkinson's disease","volume":"26","author":"Sridhar","year":"2018","journal-title":"J. Drug Target."},{"key":"10.1016\/j.jconrel.2020.07.044_bb0680","first-page":"141","article-title":"Evaluation of zidovudine encapsulated ethylcellulose microspheres prepared by water-in-oil-in-oil (w\/o\/o) double emulsion solvent diffusion technique","volume":"63","author":"Das","year":"2006","journal-title":"Acta Pol. Pharm."},{"key":"10.1016\/j.jconrel.2020.07.044_bb0685","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.1080\/03639045.2018.1483387","article-title":"Box-Behnken experimental design for preparation and optimization of the intranasal gels of selegiline hydrochloride","volume":"44","author":"Salatin","year":"2018","journal-title":"Drug Dev. Ind. Pharm."},{"key":"10.1016\/j.jconrel.2020.07.044_bb0690","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.2174\/156802608785161457","article-title":"Receptor-binding and pharmacokinetic properties of dopaminergic agonists","volume":"8","author":"Kvernmo","year":"2008","journal-title":"Curr. Top. Med. Chem."},{"key":"10.1016\/j.jconrel.2020.07.044_bb0695","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1002\/jbm.820060609","article-title":"Artificial skin. I. Preparation and properties of pluronic F-127 gels for treatment of burns","volume":"6","author":"Schmolka","year":"1972","journal-title":"J. Biomed. Mater. Res."},{"key":"10.1016\/j.jconrel.2020.07.044_bb0700","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1080\/03639045.2016.1225754","article-title":"Thermoreversible mucoadhesive in situ nasal gel for treatment of Parkinson's disease","volume":"43","author":"Rao","year":"2017","journal-title":"Drug Dev. Ind. Pharm."},{"key":"10.1016\/j.jconrel.2020.07.044_bb0705","doi-asserted-by":"crossref","first-page":"1825","DOI":"10.1016\/j.clinthera.2007.09.021","article-title":"Comprehensive review of rasagiline, a second-generation monoamine oxidase inhibitor, for the treatment of Parkinson's disease","volume":"29","author":"Chen","year":"2007","journal-title":"Clin. Ther."},{"key":"10.1016\/j.jconrel.2020.07.044_bb0710","series-title":"AZILECT; Product Monograph","author":"T.P.I. Ltd","year":"2010"},{"key":"10.1016\/j.jconrel.2020.07.044_bb0715","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/j.amjopharm.2006.12.001","article-title":"Rasagiline (TVP-1012): a new selective monoamine oxidase inhibitor for Parkinson's disease","volume":"4","author":"Guay","year":"2006","journal-title":"Am. J. Geriatr. Pharmacother."},{"key":"10.1016\/j.jconrel.2020.07.044_bb0720","series-title":"A Stable and Release-Controlled Rasagiline Transdermal Patch and Method of Preparation Thereof","author":"L.Q. Lin J","year":"2009"},{"key":"10.1016\/j.jconrel.2020.07.044_bb0725","first-page":"294","article-title":"Preparation and evaluation of intraoral drug delivery system for rasagiline mesylate","volume":"2","author":"P.K. Bukka R","year":"2010","journal-title":"Int J Pharm Sci Drug Res"},{"key":"10.1016\/j.jconrel.2020.07.044_bb0730","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1021\/js970090e","article-title":"In vitro evaluation of pluronic F127-based controlled-release ocular delivery systems for pilocarpine","volume":"87","author":"Desai","year":"1998","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.jconrel.2020.07.044_bb0735","doi-asserted-by":"crossref","first-page":"903","DOI":"10.3109\/10717544.2013.860501","article-title":"Nasal in-situ gels for delivery of rasagiline mesylate: improvement in bioavailability and brain localization","volume":"22","author":"Ravi","year":"2015","journal-title":"Drug Deliv."},{"key":"10.1016\/j.jconrel.2020.07.044_bb0740","doi-asserted-by":"crossref","first-page":"869","DOI":"10.3109\/03639045.2013.789051","article-title":"Formulation and characterization of intranasal mucoadhesive nanoparticulates and thermo-reversible gel of levodopa for brain delivery","volume":"40","author":"Sharma","year":"2014","journal-title":"Drug Dev. Ind. Pharm."},{"key":"10.1016\/j.jconrel.2020.07.044_bb0745","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1016\/j.drudis.2015.02.009","article-title":"Nanoparticle technology for treatment of Parkinson's disease: the role of surface phenomena in reaching the brain","volume":"20","author":"Leyva-G\u00f3mez","year":"2015","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.jconrel.2020.07.044_bb0750","doi-asserted-by":"crossref","first-page":"109","DOI":"10.2165\/00003088-200645020-00001","article-title":"Pharmacokinetic optimisation in the treatment of Parkinson's disease: an update","volume":"45","author":"Nyholm","year":"2006","journal-title":"Clin. Pharmacokinet."},{"key":"10.1016\/j.jconrel.2020.07.044_bb0755","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1016\/j.ijpharm.2014.07.025","article-title":"Effect of surface charge on the brain delivery of nanostructured lipid carriers in situ gels via the nasal route","volume":"473","author":"Gabal","year":"2014","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2020.07.044_bb0760","doi-asserted-by":"crossref","first-page":"4538","DOI":"10.1021\/acs.molpharmaceut.8b00537","article-title":"Boosted memory and improved brain bioavailability of rivastigmine: targeting effort to the brain using covalently tethered lower generation PAMAM dendrimers with lactoferrin","volume":"15","author":"Gothwal","year":"2018","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.jconrel.2020.07.044_bb0765","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/S0378-5173(99)00442-1","article-title":"Determination of baseline human nasal pH and the effect of intranasally administered buffers","volume":"198","author":"Washington","year":"2000","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2020.07.044_bb0770","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/j.colsurfb.2017.08.031","article-title":"Thermosensitive in situ nanocomposite of rivastigmine hydrogen tartrate as an intranasal delivery system: development, characterization, ex vivo permeation and cellular studies, colloids and surfaces B","volume":"159","author":"Salatin","year":"2017","journal-title":"Biointerfaces"},{"key":"10.1016\/j.jconrel.2020.07.044_bb0775","article-title":"Resveratrol and its biological actions","volume":"4","author":"Shah","year":"2010","journal-title":"Int. J. Green Pharm."},{"key":"10.1016\/j.jconrel.2020.07.044_bb0780","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.pbb.2013.10.007","article-title":"Antidepressant-like activity of resveratrol treatment in the forced swim test and tail suspension test in mice: the HPA axis, BDNF expression and phosphorylation of ERK","volume":"112","author":"Wang","year":"2013","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.jconrel.2020.07.044_bb0785","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.ijpharm.2004.01.039","article-title":"Preparation of nimodipine-loaded microemulsion for intranasal delivery and evaluation on the targeting efficiency to the brain","volume":"275","author":"Zhang","year":"2004","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2020.07.044_bb0790","doi-asserted-by":"crossref","first-page":"1686","DOI":"10.1080\/03639045.2017.1338721","article-title":"In vitro and in vivo evaluation of cubosomal in situ nasal gel containing resveratrol for brain targeting","volume":"43","author":"Ahirrao","year":"2017","journal-title":"Drug Dev. Ind. Pharm."},{"key":"10.1016\/j.jconrel.2020.07.044_bb0795","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.ijpharm.2014.04.015","article-title":"Development, characterization and application of in situ gel systems for intranasal delivery of tacrine","volume":"468","author":"Qian","year":"2014","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2020.07.044_bb0800","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1093\/ageing\/20.2.129","article-title":"Effects of Tetrahydroaminoacridine on Liver Function in Patients with Alzheimer's Disease","volume":"20","author":"O'Brien","year":"1991","journal-title":"Age Ageing"},{"key":"10.1016\/j.jconrel.2020.07.044_bb0805","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.ejpb.2004.03.019","article-title":"In situ-forming hydrogels\u2014review of temperature-sensitive systems","volume":"58","author":"Ruel-Gari\u00e9py","year":"2004","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.jconrel.2020.07.044_bb0810","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1111\/jphp.12043","article-title":"Enhanced brain targeting of curcumin by intranasal administration of a thermosensitive poloxamer hydrogel","volume":"65","author":"Chen","year":"2013","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.jconrel.2020.07.044_bb0815","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.brainres.2010.03.038","article-title":"RNAi therapeutics for CNS disorders","volume":"1338","author":"Boudreau","year":"2010","journal-title":"Brain Res."},{"key":"10.1016\/j.jconrel.2020.07.044_bb0820","first-page":"1373","article-title":"Increased brain radioactivity by intranasal P-labeled siRNA dendriplexes within in situ-forming mucoadhesive gels","volume":"7","author":"Perez","year":"2012","journal-title":"Int. J. Nanomedicine"},{"key":"10.1016\/j.jconrel.2020.07.044_bb0825","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1124\/jpet.103.051797","article-title":"The novel melatonin agonist agomelatine (S20098) is an antagonist at 5-hydroxytryptamine2C receptors, blockade of which enhances the activity of frontocortical dopaminergic and adrenergic pathways","volume":"306","author":"Millan","year":"2003","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.jconrel.2020.07.044_bb0830","doi-asserted-by":"crossref","first-page":"981","DOI":"10.2165\/00023210-200620120-00003","article-title":"Agomelatine: a preliminary review of a new antidepressant","volume":"20","author":"Zupancic","year":"2006","journal-title":"CNS Drugs"},{"key":"10.1016\/j.jconrel.2020.07.044_bb0835","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/j.ejps.2007.08.006","article-title":"Enhanced bioavailability of metoclopramide HCl by intranasal administration of a mucoadhesive in situ gel with modulated rheological and mucociliary transport properties","volume":"32","author":"Zaki","year":"2007","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.jconrel.2020.07.044_bb0840","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1080\/10717544.2017.1357148","article-title":"Agomelatine-based in situ gels for brain targeting via the nasal route: statistical optimization, in vitro, and in vivo evaluation","volume":"24","author":"Fatouh","year":"2017","journal-title":"Drug Deliv."},{"key":"10.1016\/j.jconrel.2020.07.044_bb0845","doi-asserted-by":"crossref","first-page":"2138","DOI":"10.1016\/S0149-2918(03)80210-2","article-title":"Venlafaxine: a 2003 update","volume":"25","author":"Gutierrez","year":"2003","journal-title":"Clin. Ther."},{"key":"10.1016\/j.jconrel.2020.07.044_bb0850","doi-asserted-by":"crossref","first-page":"1911","DOI":"10.1016\/j.drudis.2019.06.001","article-title":"Antidepressants and nose-to-brain delivery: drivers, restraints, opportunities and challenges","volume":"24","author":"Vitorino","year":"2019","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.jconrel.2020.07.044_bb0855","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1016\/j.euroneuro.2010.04.004","article-title":"Blood-brain barrier penetration of the enantiomers of venlafaxine and its metabolites in mice lacking P-glycoprotein","volume":"20","author":"Karlsson","year":"2010","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.jconrel.2020.07.044_bb0860","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1002\/j.1552-4604.1995.tb04081.x","article-title":"The pharmacokinetics of venlafaxine when given in a twice-daily regimen","volume":"35","author":"Troy","year":"1995","journal-title":"J. Clin. Pharmacol."},{"key":"10.1016\/j.jconrel.2020.07.044_bb0865","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1208\/s12249-008-9111-3","article-title":"Screening of venlafaxine hydrochloride for transdermal delivery: passive diffusion and iontophoresis","volume":"9","author":"Singh","year":"2008","journal-title":"AAPS PharmSciTech"},{"key":"10.1016\/j.jconrel.2020.07.044_bb0870","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/0378-5173(96)04441-9","article-title":"Intranasal mucociliary clearance of putative bioadhesive polymer gels","volume":"135","author":"Zhou","year":"1996","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2020.07.044_bb0875","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/S0378-5173(02)00234-X","article-title":"In vitro and in vivo evaluation of Pluronic F127-based ocular delivery system for timolol maleate","volume":"241","author":"El-Kamel","year":"2002","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2020.07.044_bb0880","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.ejps.2012.10.029","article-title":"Ex vivo permeation characteristics of venlafaxine through sheep nasal mucosa","volume":"48","author":"Pund","year":"2013","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.jconrel.2020.07.044_bb0885","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1111\/j.1600-0447.1997.tb10162.x","article-title":"A comparison of quetiapine and chlorpromazine in the treatment of schizophrenia","volume":"96","author":"Peuskens","year":"1997","journal-title":"Acta Psychiatr. Scand."},{"key":"10.1016\/j.jconrel.2020.07.044_bb0890","doi-asserted-by":"crossref","first-page":"213","DOI":"10.2165\/11597330-000000000-00000","article-title":"Effect of quetiapine and norquetiapine on anxiety and depression in major psychoses using a pharmacokinetic approach: a prospective observational study","volume":"32","author":"Altamura","year":"2012","journal-title":"Clin. Drug Investig."},{"key":"10.1016\/j.jconrel.2020.07.044_bb0895","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1017\/S1461145711001556","article-title":"Quetiapine affects neuropeptide Y and corticotropin-releasing hormone in cerebrospinal fluid from schizophrenia patients: relationship to depression and anxiety symptoms and to treatment response","volume":"15","author":"Nikisch","year":"2012","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.jconrel.2020.07.044_bb0900","first-page":"884","article-title":"Factors affecting drug absorption and improvement measures for nasal in situ gel delivery system","volume":"8","author":"S.S. Qian JJ","year":"2012","journal-title":"Chin. J.f New Drugs"},{"key":"10.1016\/j.jconrel.2020.07.044_bb0905","doi-asserted-by":"crossref","first-page":"2607","DOI":"10.2217\/nnm-2017-0082","article-title":"Stearic acid based, systematically designed oral lipid nanoparticles for enhanced brain delivery of dimethyl fumarate","volume":"12","author":"Kumar","year":"2017","journal-title":"Nanomed."},{"key":"10.1016\/j.jconrel.2020.07.044_bb0910","first-page":"17590","article-title":"Preparation and brain delivery of nasal solid lipid nanoparticles of quetiapine fumarate in situ gel in rat model of schizophrenia","volume":"8","author":"Li","year":"2015","journal-title":"Int. J. Clin. Exp. Med."},{"key":"10.1016\/j.jconrel.2020.07.044_bb0915","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/j.ijpharm.2012.10.049","article-title":"Thermo-sensitive gels containing lorazepam microspheres for intranasal brain targeting","volume":"441","author":"Jose","year":"2013","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2020.07.044_bb0920","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1016\/S0140-6736(06)68696-0","article-title":"Efficacy and safety of intranasal lorazepam versus intramuscular paraldehyde for protracted convulsions in children: an open randomised trial","volume":"367","author":"Ahmad","year":"2006","journal-title":"Lancet (London, England)"},{"key":"10.1016\/j.jconrel.2020.07.044_bb0925","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1093\/qjmed\/95.4.225","article-title":"A comparison of lorazepam and diazepam as initial therapy in convulsive status epilepticus","volume":"95","author":"Cock","year":"2002","journal-title":"QJM"},{"key":"10.1016\/j.jconrel.2020.07.044_bb0930","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1002\/jps.20480","article-title":"Intranasal mucoadhesive microemulsions of clonazepam: preliminary studies on brain targeting","volume":"95","author":"Vyas","year":"2006","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.jconrel.2020.07.044_bb0935","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.ejpb.2005.04.004","article-title":"Baclofen-loaded microspheres in gel suspensions for intrathecal drug delivery: in vitro and in vivo evaluation","volume":"61","author":"Lagarce","year":"2005","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.jconrel.2020.07.044_bb0940","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/S0168-3659(02)00363-2","article-title":"Nasal drug delivery--possibilities, problems and solutions","volume":"87","author":"Illum","year":"2003","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2020.07.044_bb0945","doi-asserted-by":"crossref","first-page":"431","DOI":"10.2165\/00023210-200317060-00005","article-title":"The triptan formulations: how to match patients and products","volume":"17","author":"Rapoport","year":"2003","journal-title":"CNS Drugs"},{"key":"10.1016\/j.jconrel.2020.07.044_bb0950","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1046\/j.1468-2982.2001.218233.x","article-title":"Vascular effects of the new anti-migraine agent almotriptan on human cranial and peripheral arteries","volume":"21","author":"Bou","year":"2001","journal-title":"Cephalalgia"},{"key":"10.1016\/j.jconrel.2020.07.044_bb0955","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.jpba.2013.04.008","article-title":"LC-MS\/MS method for the quantification of almotriptan in dialysates: application to rat brain and blood microdialysis study","volume":"81-82","author":"Nirogi","year":"2013","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.jconrel.2020.07.044_bb0960","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.pharmthera.2005.04.010","article-title":"New and future migraine therapy","volume":"112","author":"Ramadan","year":"2006","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.jconrel.2020.07.044_bb0965","first-page":"88","article-title":"Development of zolmitriptan gel for nasal administration","volume":"5","author":"Kolsure","year":"2012","journal-title":"Asian J. Pharma.l and Clin. Res."},{"key":"10.1016\/j.jconrel.2020.07.044_bb0970","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/j.ijpharm.2018.07.014","article-title":"A novel nasal almotriptan loaded solid lipid nanoparticles in mucoadhesive in situ gel formulation for brain targeting: preparation, characterization and in vivo evaluation","volume":"548","author":"Youssef","year":"2018","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2020.07.044_bb0975","doi-asserted-by":"crossref","first-page":"1832","DOI":"10.1212\/WNL.54.9.1832","article-title":"Oral zolmitriptan is effective in the acute treatment of cluster headache","volume":"54","author":"Bahra","year":"2000","journal-title":"Neurology"},{"key":"10.1016\/j.jconrel.2020.07.044_bb0980","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1046\/j.1468-2982.2002.00319.x","article-title":"Zolmitriptan orally disintegrating tablet is effective in the acute treatment of migraine","volume":"22","author":"Dowson","year":"2002","journal-title":"Cephalalgia"},{"key":"10.1016\/j.jconrel.2020.07.044_bb0985","doi-asserted-by":"crossref","first-page":"70","DOI":"10.2174\/157488909787002555","article-title":"Individual triptan selection in migraine attack therapy","volume":"4","author":"Belvis","year":"2009","journal-title":"Recent Patents CNS Drug Discov."},{"key":"10.1016\/j.jconrel.2020.07.044_bb0990","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1177\/009127002762491325","article-title":"Preliminary studies of the pharmacokinetics and tolerability of zolmitriptan nasal spray in healthy volunteers","volume":"42","author":"Yates","year":"2002","journal-title":"J. Clin. Pharmacol."},{"key":"10.1016\/j.jconrel.2020.07.044_bb0995","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1212\/WNL.49.5.1219","article-title":"Clinical efficacy and tolerability of 2.5 mg zolmitriptan for the acute treatment of migraine. The 042 Clinical Trial Study Group","volume":"49","author":"Solomon","year":"1997","journal-title":"Neurology"},{"key":"10.1016\/j.jconrel.2020.07.044_bb1000","doi-asserted-by":"crossref","first-page":"313","DOI":"10.3109\/08982104.2015.1132232","article-title":"Poloxamer 407-based intranasal thermoreversible gel of zolmitriptan-loaded nanoethosomes: formulation, optimization, evaluation and permeation studies","volume":"26","author":"Shelke","year":"2016","journal-title":"J. Liposome Res."},{"key":"10.1016\/j.jconrel.2020.07.044_bb1005","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1592\/phco.2006.26.1.115","article-title":"Safety and efficacy of eletriptan in the treatment of acute migraine","volume":"26","author":"Takiya","year":"2006","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.jconrel.2020.07.044_bb1010","doi-asserted-by":"crossref","first-page":"559","DOI":"10.2174\/1568026023393903","article-title":"Recent advances in 5-HT1B\/1D receptor antagonists and agonists and their potential therapeutic applications","volume":"2","author":"Slassi","year":"2002","journal-title":"Curr. Top. Med. Chem."},{"key":"10.1016\/j.jconrel.2020.07.044_bb1015","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.brainres.2003.11.018","article-title":"The 5-hydroxytryptamine1B\/1D\/1F receptor agonists eletriptan and naratriptan inhibit trigeminovascular input to the nucleus tractus solitarius in the cat","volume":"998","author":"Hoskin","year":"2004","journal-title":"Brain Res."},{"key":"10.1016\/j.jconrel.2020.07.044_bb1020","first-page":"51","article-title":"Human hepatocytes in primary culture predict lack of cytochrome P-450 3A4 induction by eletriptan in vivo","volume":"28","author":"Pichard-Garcia","year":"2000","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.jconrel.2020.07.044_bb1025","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/S0378-5173(97)00386-4","article-title":"Development of in situ-gelling and mucoadhesive acetaminophen liquid suppository","volume":"165","author":"Choi","year":"1998","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2020.07.044_bb1030","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1007\/s10856-016-5713-6","article-title":"Thermoreversible nanoethosomal gel for the intranasal delivery of Eletriptan hydrobromide","volume":"27","author":"Shelke","year":"2016","journal-title":"J. Mater. Sci. Mater. Med."},{"key":"10.1016\/j.jconrel.2020.07.044_bb1035","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.brainres.2012.04.032","article-title":"Buspirone: what is it all about?","volume":"1461","author":"Loane","year":"2012","journal-title":"Brain Res."},{"key":"10.1016\/j.jconrel.2020.07.044_bb1040","doi-asserted-by":"crossref","first-page":"270","DOI":"10.2174\/15701638113109990031","article-title":"Formulation and evaluation of niosomal nasal drug delivery system of folic acid for brain targeting","volume":"10","author":"Ravouru","year":"2013","journal-title":"Curr. Drug Discov. Technol."},{"key":"10.1016\/j.jconrel.2020.07.044_bb1045","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ijpharm.2007.03.025","article-title":"Intranasal delivery: physicochemical and therapeutic aspects","volume":"337","author":"Costantino","year":"2007","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2020.07.044_bb1050","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1007\/s13346-016-0296-9","article-title":"Formulation and evaluation of proniosomes containing lornoxicam","volume":"6","author":"Madan","year":"2016","journal-title":"Drug Deliv. Transl. Res."},{"key":"10.1016\/j.jconrel.2020.07.044_bb1055","article-title":"Preparation, optimization and characterization of ketoprofen proniosomes for transdermal delivery","volume":"2","author":"Solanki","year":"2009","journal-title":"Int. J. Pharm. Nanotechnol."},{"key":"10.1016\/j.jconrel.2020.07.044_bb1060","doi-asserted-by":"crossref","first-page":"107","DOI":"10.3109\/08982104.2014.941861","article-title":"Oro-dental mucoadhesive proniosomal gel formulation loaded with lornoxicam for management of dental pain","volume":"25","author":"Abdelbary","year":"2015","journal-title":"J. Liposome Res."},{"key":"10.1016\/j.jconrel.2020.07.044_bb1065","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1080\/03639040701831710","article-title":"In situ ophthalmic gel of ciprofloxacin hydrochloride for once a day sustained delivery","volume":"34","author":"Jain","year":"2008","journal-title":"Drug Dev. Ind. Pharm."},{"key":"10.1016\/j.jconrel.2020.07.044_bb1070","doi-asserted-by":"crossref","first-page":"69","DOI":"10.2174\/2211738506666180130105919","article-title":"Formulation and evaluation of niosomal in situ nasal gel of a serotonin receptor agonist, buspirone hydrochloride for the brain delivery via intranasal route","volume":"6","author":"Mathure","year":"2018","journal-title":"Pharm. Nanotechnol."},{"key":"10.1016\/j.jconrel.2020.07.044_bb1075","doi-asserted-by":"crossref","unstructured":"R.T. Owen, Extended-release paliperidone: efficacy, safety and tolerability profile of a new atypical antipsychotic, Drugs Today (Barcelona, Spain 1998), 43 (2007) 249-258.","DOI":"10.1358\/dot.2007.43.4.1067342"},{"key":"10.1016\/j.jconrel.2020.07.044_bb1080","doi-asserted-by":"crossref","first-page":"869","DOI":"10.2147\/NDT.S1365","article-title":"Paliperidone ER: a review of the clinical trial data","volume":"3","author":"Janicak","year":"2007","journal-title":"Neuropsychiatr. Dis. Treat."},{"key":"10.1016\/j.jconrel.2020.07.044_bb1085","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/S0169-409X(97)00069-0","article-title":"Microspheres as nasal drug delivery systems","volume":"29","author":"Pereswetoff-Morath","year":"1998","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2020.07.044_bb1090","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/S0378-5173(99)00026-5","article-title":"Thermally reversible xyloglucan gels as vehicles for oral drug delivery","volume":"181","author":"Kawasaki","year":"1999","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2020.07.044_bb1095","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1023\/A:1015921101465","article-title":"Absorption of polyethylene glycols 600 through 2000: the molecular weight dependence of gastrointestinal and nasal absorption","volume":"7","author":"Donovan","year":"1990","journal-title":"Pharm. Res."},{"key":"10.1016\/j.jconrel.2020.07.044_bb1100","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1023\/A:1015880502548","article-title":"Interspecies differences in the nasal absorption of insulin","volume":"8","author":"Merkus","year":"1991","journal-title":"Pharm. Res."},{"key":"10.1016\/j.jconrel.2020.07.044_bb1105","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1023\/B:PHAM.0000032998.84488.7a","article-title":"Cyclodextrins in nasal delivery of low-molecular-weight heparins: in vivo and in vitro studies","volume":"21","author":"Yang","year":"2004","journal-title":"Pharm. Res."},{"key":"10.1016\/j.jconrel.2020.07.044_bb1110","doi-asserted-by":"crossref","first-page":"17","DOI":"10.3109\/10611869808997878","article-title":"Efficacy, safety and mechanism of cyclodextrins as absorption enhancers in nasal delivery of peptide and protein drugs","volume":"6","author":"Marttin","year":"1998","journal-title":"J. Drug Target."},{"key":"10.1016\/j.jconrel.2020.07.044_bb1115","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.ijpharm.2015.05.009","article-title":"Nasal delivery of analgesic ketorolac tromethamine thermo- and ion-sensitive in situ hydrogels","volume":"489","author":"Li","year":"2015","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2020.07.044_bb1120","doi-asserted-by":"crossref","first-page":"2589","DOI":"10.1016\/j.xphs.2016.04.007","article-title":"Brain-targeting chemical delivery systems and their cyclodextrin-based formulations in light of the contributions of Marcus E. Brewster","volume":"105","author":"Buchwald","year":"2016","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.jconrel.2020.07.044_bb1125","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1016\/j.jocn.2007.02.006","article-title":"Cognitive impairment in multiple sclerosis: evidence-based analysis and recommendations","volume":"14","author":"Rogers","year":"2007","journal-title":"J. Clin. Neurosci."},{"key":"10.1016\/j.jconrel.2020.07.044_bb1130","doi-asserted-by":"crossref","first-page":"6726","DOI":"10.2174\/1381612811319380005","article-title":"Resveratrol: new avenues for a natural compound in neuroprotection","volume":"19","author":"Pallas","year":"2013","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.jconrel.2020.07.044_bb1135","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1016\/j.ijbiomac.2014.03.022","article-title":"Ali, Donepezil nanosuspension intended for nose to brain targeting: in vitro and in vivo safety evaluation","volume":"67","author":"Bhavna","year":"2014","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.jconrel.2020.07.044_bb1140","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.ijpharm.2015.03.001","article-title":"Solid lipid nanoparticles loaded with lipoyl-memantine codrug: preparation and characterization","volume":"485","author":"Laserra","year":"2015","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2020.07.044_bb1145","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.2174\/092986712799945085","article-title":"Resveratrol in medicinal chemistry: a critical review of its pharmacokinetics, drug-delivery, and membrane interactions","volume":"19","author":"Neves","year":"2012","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.jconrel.2020.07.044_bb1150","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1002\/mnfr.200500002","article-title":"Bioavailability of trans-resveratrol from red wine in humans","volume":"49","author":"Vitaglione","year":"2005","journal-title":"Mol. Nutr. Food Res."},{"key":"10.1016\/j.jconrel.2020.07.044_bb1155","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1208\/s12249-011-9678-y","article-title":"Formulation and evaluation of in situ gelling systems for intranasal administration of gastrodin","volume":"12","author":"Cai","year":"2011","journal-title":"AAPS PharmSciTech"},{"key":"10.1016\/j.jconrel.2020.07.044_bb1160","first-page":"1460","article-title":"In situ nanostructured hydrogel of resveratrol for brain targeting: in vitro-in vivo characterization","volume":"8","author":"Rajput","year":"2018","journal-title":"Comp. Stud."},{"key":"10.1016\/j.jconrel.2020.07.044_bb1165","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/j.colsurfb.2016.08.011","article-title":"Fabrication of an ionic-sensitive in situ gel loaded with resveratrol nanosuspensions intended for direct nose-to-brain delivery, Colloids and surfaces B","volume":"147","author":"Hao","year":"2016","journal-title":"Biointerfaces"},{"key":"10.1016\/j.jconrel.2020.07.044_bb1170","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/j.ijpharm.2015.01.003","article-title":"Resveratrol nanoformulations: challenges and opportunities","volume":"479","author":"Summerlin","year":"2015","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2020.07.044_bb1175","article-title":"Cognitive improvement by vorinostat through modulation of endoplasmic reticulum stress in a corticosterone-induced chronic stress model in mice","author":"V.A. K","year":"2020","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.jconrel.2020.07.044_bb1180","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/S0091-3057(03)00111-4","article-title":"The psychopharmacology of huperzine A: an alkaloid with cognitive enhancing and neuroprotective properties of interest in the treatment of Alzheimer's disease","volume":"75","author":"Zangara","year":"2003","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.jconrel.2020.07.044_bb1185","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1111\/j.1745-7254.2007.00486.x","article-title":"Drug brain distribution following intranasal administration of Huperzine A in situ gel in rats","volume":"28","author":"Zhao","year":"2007","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.jconrel.2020.07.044_bb1190","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/j.yebeh.2005.12.009","article-title":"Tian ma, an ancient Chinese herb, offers new options for the treatment of epilepsy and other conditions","volume":"8","author":"Ojemann","year":"2006","journal-title":"Epilepsy Behav."},{"key":"10.1016\/j.jconrel.2020.07.044_bb1195","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1248\/bpb.30.801","article-title":"A microdialysis study of effects of gastrodin on neurochemical changes in the ischemic\/reperfused rat cerebral hippocampus","volume":"30","author":"Zeng","year":"2007","journal-title":"Biol. Pharm. Bull."},{"key":"10.1016\/j.jconrel.2020.07.044_bb1200","doi-asserted-by":"crossref","first-page":"24","DOI":"10.3389\/fphar.2018.00024","article-title":"A review on central nervous system effects of Gastrodin","volume":"9","author":"Liu","year":"2018","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.jconrel.2020.07.044_bb1205","first-page":"79","article-title":"Study of the mechanism of gastrodin and derivatives of gastrodigenin","volume":"22","author":"Guo","year":"1991","journal-title":"Hua xi yi ke da xue xue bao = Journal of West China University of Medical Sciences = Huaxi yike daxue xuebao"},{"key":"10.1016\/j.jconrel.2020.07.044_bb1210","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.ijpharm.2007.03.041","article-title":"Pharmacokinetics of Gastrodin in rat plasma and CSF after i.n. and i.v","volume":"341","author":"Wang","year":"2007","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2020.07.044_bb1215","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1208\/pt070367","article-title":"Thermoreversible-mucoadhesive gel for nasal delivery of sumatriptan","volume":"7","author":"Majithiya","year":"2006","journal-title":"AAPS PharmSciTech"},{"key":"10.1016\/j.jconrel.2020.07.044_bb1220","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1212\/WNL.49.5.1225","article-title":"Sumatriptan nasal spray for the acute treatment of migraine. Results of two clinical studies","volume":"49","author":"Ryan","year":"1997","journal-title":"Neurology"},{"key":"10.1016\/j.jconrel.2020.07.044_bb1225","doi-asserted-by":"crossref","first-page":"62","DOI":"10.3109\/10717544.2013.849778","article-title":"Development of in situ gel for nasal delivery: design, optimization, in vitro and in vivo evaluation","volume":"21","author":"Galgatte","year":"2014","journal-title":"Drug Deliv."},{"key":"10.1016\/j.jconrel.2020.07.044_bb1230","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.jns.2007.06.057","article-title":"Protective effects of paeonol on cultured rat hippocampal neurons against oxygen-glucose deprivation-induced injury","volume":"264","author":"Wu","year":"2008","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.jconrel.2020.07.044_bb1235","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.brainresbull.2014.09.008","article-title":"Paeonol pretreatment attenuates cerebral ischemic injury via upregulating expression of pAkt, Nrf2, HO-1 and ameliorating BBB permeability in mice","volume":"109","author":"Zhao","year":"2014","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.jconrel.2020.07.044_bb1240","doi-asserted-by":"crossref","first-page":"2397","DOI":"10.3892\/mmr.2016.5573","article-title":"Therapeutic effects of paeonol on methyl-4-phenyl-1,2,3,6-tetrahydropyridine\/probenecid-induced Parkinson's disease in mice","volume":"14","author":"Shi","year":"2016","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.jconrel.2020.07.044_bb1245","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1055\/s-0031-1280269","article-title":"Influence of co-administered danshensu on pharmacokinetic fate and tissue distribution of paeonol in rats","volume":"78","author":"Li","year":"2012","journal-title":"Planta Med."},{"key":"10.1016\/j.jconrel.2020.07.044_bb1250","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.jchromb.2017.09.015","article-title":"Systematic characterization of the metabolites of paeonol in rats using ultra performance liquid chromatography coupled with electrospray ionization quadrupole time-of-flight tandem mass spectrometry with an integrative strategy","volume":"1065-1066","author":"Ding","year":"2017","journal-title":"J. Chromatogr. B"},{"key":"10.1016\/j.jconrel.2020.07.044_bb1255","series-title":"An Available Strategy for Nasal Brain Transport of Nanocomposite Based on PAMAM Dendrimers via In Situ Gel","volume":"9","author":"Xie","year":"2019"},{"key":"10.1016\/j.jconrel.2020.07.044_bb1260","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.ijpharm.2019.01.044","article-title":"In situ thermo-co-electroresponsive mucogel for controlled release of bioactive agent","volume":"559","author":"Akilo","year":"2019","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2020.07.044_bb1265","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/j.carbpol.2016.08.068","article-title":"Thermo-sensitive injectable hydrogel based on the physical mixing of hyaluronic acid and Pluronic F-127 for sustained NSAID delivery","volume":"156","author":"Jung","year":"2017","journal-title":"Carbohydr. Polym."},{"key":"10.1016\/j.jconrel.2020.07.044_bb1270","doi-asserted-by":"crossref","first-page":"2964","DOI":"10.1038\/s41598-017-03123-y","article-title":"Pluronic F127 and D-alpha-tocopheryl polyethylene glycol succinate (TPGS) mixed micelles for targeting drug delivery across the blood brain barrier","volume":"7","author":"Meng","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jconrel.2020.07.044_bb1275","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1208\/s12249-012-9823-2","article-title":"Statistical approach for assessing the influence of calcium silicate and HPMC on the formulation of novel alfuzosin hydrochloride mucoadhesive-floating beads as gastroretentive drug delivery systems","volume":"13","author":"Fahmy","year":"2012","journal-title":"AAPS PharmSciTech"},{"key":"10.1016\/j.jconrel.2020.07.044_bb1280","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1208\/s12249-017-0720-6","article-title":"Development and evaluation of buccal films based on chitosan for the potential treatment of oral candidiasis","volume":"18","author":"Tejada","year":"2017","journal-title":"AAPS PharmSciTech"},{"key":"10.1016\/j.jconrel.2020.07.044_bb1285","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1021\/nn204688c","article-title":"Polyaniline-grafted reduced graphene oxide for efficient electrochemical supercapacitors","volume":"6","author":"Kumar","year":"2012","journal-title":"ACS Nano"},{"key":"10.1016\/j.jconrel.2020.07.044_bb1290","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1080\/17458080.2012.656713","article-title":"Investigation of electroactive behaviour of polyaniline containing polyelectrolyte nanocomposite membranes","volume":"1","author":"Soni","year":"2012","journal-title":"Nanosci. Methods"},{"key":"10.1016\/j.jconrel.2020.07.044_bb1295","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1016\/j.electacta.2017.03.084","article-title":"Redox solid energy boosters for flow batteries: polyaniline as a case study","volume":"235","author":"Zanzola","year":"2017","journal-title":"Electrochim. Acta"},{"key":"10.1016\/j.jconrel.2020.07.044_bb1300","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1208\/s12249-010-9477-x","article-title":"Development and characterization of mucoadhesive in situ nasal gel of midazolam prepared with Ficus carica mucilage","volume":"11","author":"Basu","year":"2010","journal-title":"AAPS PharmSciTech"},{"key":"10.1016\/j.jconrel.2020.07.044_bb1305","doi-asserted-by":"crossref","first-page":"1634","DOI":"10.1016\/S0149-2918(03)80160-1","article-title":"A review of rivastigmine: a reversible cholinesterase inhibitor","volume":"25","author":"Williams","year":"2003","journal-title":"Clin. Ther."},{"key":"10.1016\/j.jconrel.2020.07.044_bb1310","doi-asserted-by":"crossref","first-page":"6031","DOI":"10.1016\/j.biomaterials.2010.04.009","article-title":"Tyrosine-based rivastigmine-loaded organogels in the treatment of Alzheimer's disease","volume":"31","author":"Bastiat","year":"2010","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2020.07.044_bb1315","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.brainres.2008.01.039","article-title":"Poly(n-butylcyanoacrylate) nanoparticles coated with polysorbate 80 for the targeted delivery of rivastigmine into the brain to treat Alzheimer's disease","volume":"1200","author":"Wilson","year":"2008","journal-title":"Brain Res."},{"key":"10.1016\/j.jconrel.2020.07.044_bb1320","doi-asserted-by":"crossref","first-page":"141","DOI":"10.3109\/08982104.2014.954129","article-title":"Rivastigmine-loaded in situ gelling nanostructured lipid carriers for nose to brain delivery","volume":"25","author":"Wavikar","year":"2015","journal-title":"J. Liposome Res."},{"key":"10.1016\/j.jconrel.2020.07.044_bb1325","doi-asserted-by":"crossref","first-page":"3613","DOI":"10.1016\/j.xphs.2017.08.024","article-title":"Nose to brain delivery of rivastigmine by in situ gelling cationic nanostructured lipid carriers: enhanced brain distribution and pharmacodynamics","volume":"106","author":"Wavikar","year":"2017","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.jconrel.2020.07.044_bb1330","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1155\/2014\/847547","article-title":"Formulation and Evaluation of Thermosensitive Biogels for Nose to Brain Delivery of Doxepin","volume":"2014","author":"Naik","year":"2014","journal-title":"Biomed. Res. Int."},{"key":"10.1016\/j.jconrel.2020.07.044_bb1335","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/0378-5173(95)00045-K","article-title":"In vivo evaluation of spray formulations of human insulin for nasal delivery","volume":"122","author":"Dondeti","year":"1995","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2020.07.044_bb1340","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/S0144-8617(00)00281-2","article-title":"Rheological characterisation of thermogelling chitosan\/glycerol-phosphate solutions","volume":"46","author":"Chenite","year":"2001","journal-title":"Carbohydr. Polym."},{"key":"10.1016\/j.jconrel.2020.07.044_bb1345","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1080\/02648725.2010.10648153","article-title":"Polysaccharide drug delivery systems based on pectin and chitosan","volume":"27","author":"Morris","year":"2010","journal-title":"Biotechnol. Genet. Eng. Rev."},{"key":"10.1016\/j.jconrel.2020.07.044_bb1350","doi-asserted-by":"crossref","first-page":"2220","DOI":"10.1016\/j.biomaterials.2006.12.024","article-title":"A thermosensitive hydrogel based on quaternized chitosan and poly(ethylene glycol) for nasal drug delivery system","volume":"28","author":"Wu","year":"2007","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2020.07.044_bb1355","doi-asserted-by":"crossref","first-page":"1596","DOI":"10.1248\/cpb.56.1596","article-title":"Design and evaluation of bioadhesive in-situ nasal gel of ketorolac tromethamine","volume":"56","author":"Chelladurai","year":"2008","journal-title":"Chem. Pharm. Bull."},{"key":"10.1016\/j.jconrel.2020.07.044_bb1360","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1517\/17425240902939135","article-title":"PecSys: in situ gelling system for optimised nasal drug delivery","volume":"6","author":"Watts","year":"2009","journal-title":"Expert Opin. Drug Deliv."},{"key":"10.1016\/j.jconrel.2020.07.044_bb1365","doi-asserted-by":"crossref","first-page":"319","DOI":"10.5055\/jom.2010.0029","article-title":"Long-term safety, tolerability, and consistency of effect of fentanyl pectin nasal spray for breakthrough cancer pain in opioid-tolerant patients","volume":"6","author":"Portenoy","year":"2010","journal-title":"J Opioid Manag."},{"key":"10.1016\/j.jconrel.2020.07.044_bb1370","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.ijpharm.2012.03.054","article-title":"Thermosensitive and mucoadhesive in situ gel based on poloxamer as new carrier for rectal administration of nimesulide","volume":"430","author":"Yuan","year":"2012","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2020.07.044_bb1375","doi-asserted-by":"crossref","first-page":"780","DOI":"10.3109\/03639045.2012.707203","article-title":"Design and development of a novel pH triggered nanoemulsified in-situ ophthalmic gel of fluconazole: ex-vivo transcorneal permeation, corneal toxicity and irritation testing","volume":"39","author":"Pathak","year":"2013","journal-title":"Drug Dev. Ind. Pharm."},{"key":"10.1016\/j.jconrel.2020.07.044_bb1380","doi-asserted-by":"crossref","first-page":"535","DOI":"10.4155\/tde.12.16","article-title":"Hydrogels in mucosal delivery","volume":"3","author":"Nazar","year":"2012","journal-title":"Ther. Deliv."},{"key":"10.1016\/j.jconrel.2020.07.044_bb1385","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1016\/j.addr.2011.10.007","article-title":"Nanotechnological advances for the delivery of CNS therapeutics","volume":"64","author":"Wong","year":"2012","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2020.07.044_bb1390","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.3390\/cancers5031020","article-title":"Formulations for intranasal delivery of pharmacological agents to combat brain disease: a new opportunity to tackle GBM?","volume":"5","author":"van Woensel","year":"2013","journal-title":"Cancers"},{"key":"10.1016\/j.jconrel.2020.07.044_bb7000","first-page":"309","article-title":"Classification and Formulation Development of Solid Dispersion of Poorly Water Soluble Drugs: An Updated Review","volume":"1","author":"Giri","year":"2010","journal-title":"International Journal of Pharmaceutical and Biological Archives"},{"issue":"4","key":"10.1016\/j.jconrel.2020.07.044_bb7005","doi-asserted-by":"crossref","first-page":"621","DOI":"10.2174\/1567201813666160204114000","article-title":"Understanding the role of poloxamer 407 based thermoreversible in situ gelling hydrogel for delivery of PEGylated melphalan conjugate","volume":"13","author":"Alexander","year":"2016","journal-title":"Current Drug Delivery"},{"issue":"10","key":"10.1016\/j.jconrel.2020.07.044_bb7010","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1111\/jphp.12280","article-title":"Luteolin-phospholipid complex: Preparation, characterization and biological evaluation","volume":"66","author":"Khan","year":"2014","journal-title":"Journal of Pharmacy and Pharmacology"},{"issue":"9","key":"10.1016\/j.jconrel.2020.07.044_bb7015","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1111\/jphp.12262","article-title":"Formulation and evaluation of chitosan-based long-acting injectable hydrogel for PEGylated melphalan conjugate","volume":"66","author":"Alexander","year":"2014","journal-title":"Journal of Pharmacy and Pharmacology"}],"container-title":["Journal of Controlled Release"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365920304284?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365920304284?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,15]],"date-time":"2024-06-15T03:10:21Z","timestamp":1718421021000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168365920304284"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11]]},"references-count":282,"alternative-id":["S0168365920304284"],"URL":"https:\/\/doi.org\/10.1016\/j.jconrel.2020.07.044","relation":{},"ISSN":["0168-3659"],"issn-type":[{"value":"0168-3659","type":"print"}],"subject":[],"published":{"date-parts":[[2020,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Stimuli-responsive In situ gelling system for nose-to-brain drug delivery","name":"articletitle","label":"Article Title"},{"value":"Journal of Controlled Release","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jconrel.2020.07.044","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}